Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension

Hypertension

Volumn 65, Issue 3, 2015, Pages 600-606

  Veerbeek, Jan H W ^a   Hermes, Wietske ^b,c   Breimer, Anath Y ^a   Van Rijn, Bas B ^a,e   Koenen, Steven V ^a   Mol, Ben W ^d   Franx, Arie ^a   De Groot, Christianne J M ^c   Koster, Maria P H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

hypertension; prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LIPID;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; NULLIPARA; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; SMALL FOR DATE INFANT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; AGE; BLOOD; CARDIOVASCULAR DISEASES; HYPERTENSION, PREGNANCY-INDUCED; METABOLISM; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGE FACTORS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LIPIDS; OUTCOME ASSESSMENT (HEALTH CARE); PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84924257645     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04850     Document Type: Article

References (33)

1. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974. doi: 10.1136/bmj.39335.385301.BE.
2. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1-19. doi: 10.1007/s10654-013-9762-6.
3. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797-1803. doi: 10.1016/S0140-6736(05)67726-4.
4. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-799. doi: 10.1016/S0140-6736(05)17987-2.
5. Manten GT, Sikkema MJ, Voorbij HA, Visser GH, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy. 2007;26:39-50. doi: 10.1080/10641950601146574.
6. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension. 2003;42:39-42. doi: 10.1161/01.HYP.0000074428.11168.EE.
7. Veltman-Verhulst SM, van Rijn BB, Westerveld HE, Franx A, Bruinse HW, Fauser BC, Goverde AJ. Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk. Menopause. 2010;17:990-996. doi: 10.1097/gme.0b013e3181ddf705.
8. van Rijn BB, Nijdam ME, Bruinse HW, Roest M, Uiterwaal CS, Grobbee DE, Bots ML, Franx A. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol. 2013;121:1040-1048. doi: 10.1097/AOG.0b013e31828ea3b5.
9. Veerbeek JH, Smit JG, Koster MP, Post Uiterweer ED, van Rijn BB, Koenen SV, Franx A. Maternal cardiovascular risk profile after placental abruption. Hypertension. 2013;61:1297-1301. doi: 10.1161/HYPERTENSIONAHA.111.00930.
10. Hermes W, Franx A, van Pampus MG, Bloemenkamp KW, van der Post JA, Porath M, Ponjee G, Tamsma JT, Mol BW, de Groot CJ. 10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study. BMC Pregnancy Childbirth. 2010;10:28. doi: 10.1186/1471-2393-10-28.
11. Koopmans CM, Bijlenga D, Groen H, et al HYPITAT Study Group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979-988. doi: 10.1016/S0140-6736(09)60736-4.
12. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:IX-XIV. doi: 10.1081/PRG-100104165.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
14. Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM. New Dutch reference curves for birthweight by gestational age. Early Hum Dev. 2009;85:737-744. doi: 10.1016/j.earlhumdev.2009.09.008.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. doi: 10.1161/01.HYP.0000107251.49515.c2.
16. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-1062. doi: 10.1016/S0140-6736(05)67402-8.
17. Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 2010;121:1069-1077. doi: 10.1161/CIRCULATIONAHA.109.906479.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497.
19. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
20. Moons KG, Donders RA, Stijnen T, Harrell FE, Jr. Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol. 2006;59:1092-1101. doi: 10.1016/j.jclinepi.2006.01.009.
21. Wikström AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG. 2005;112:1486-1491. doi: 10.1111/j.1471-0528.2005.00733.x.
22. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944-951. doi: 10.1161/HYPERTENSIONAHA.109.130765.
23. Blokstra A, Vissink P, Venmans L, Holleman P, van der Schouw Y, Smit H, Verschuren W. Nederland de Maat Genomen, 2009-2010. Monitoring van risicofactoren in de algemene bevolking. 2011; 260152001/2011.
24. Stergiotou I, Crispi F, Valenzuela-Alcaraz B, Bijnens B, Gratacos E. Patterns of maternal vascular remodeling and responsiveness in early- versus late-onset preeclampsia. Am J Obstet Gynecol. 2013;209:558.e1-558.e14. doi: 10.1016/j.ajog.2013.07.030.
25. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873-880. doi: 10.1161/HYPERTENSIONAHA.108.117358.
26. Staff AC, Dechend R, Redman CW. Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta. 2013;34(suppl):S73-S78. doi: 10.1016/j.placenta.2012.11.022.
27. Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med. 2006;145:35-42.
28. Morrissey RP, Diamond GA, Kaul S. The JUPITER trial: myth or reality? Curr Atheroscler Rep. 2011;13:413-421. doi: 10.1007/s11883-011-0197-9.
29. Halcox JP, Roy C, Tubach F, Banegas JR, Dallongeville J, De Backer G, Guallar E, Sazova O, Medina J, Perk J, Steg PG, Rodríguez-Artalejo F, Borghi C. C-reactive protein levels in patients at cardiovascular risk: EURIKA study. BMC Cardiovasc Disord. 2014;14:25. doi: 10.1186/1471-2261-14-25.
30. van Rijn BB, Veerbeek JH, Scholtens LC, Post Uiterweer ED, Koster MP, Peeters LL, Koenen SV, Bruinse HW, Franx A. C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia: a prospective cohort study. J Hypertens. 2014;32:408-414. doi: 10.1097/HJH.0000000000000027.
31. van Dam RM, Schuit AJ, Schouten EG, Vader HL, Pop VJ. Serum cholesterol decline and depression in the postpartum period. J Psychosom Res. 1999;46:385-390.
32. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979;133 :165-170.
33. Lloyd-Jones DM, Leip EP, Larson MG, Vasan RS, Levy D. Novel approach to examining first cardiovascular events after hypertension onset. Hypertension. 2005;45:39-45. doi: 10.1161/01.HYP.0000149106.89470.13.